阿西米尼维持抗白血病原始细胞的抗体依赖细胞介导的细胞毒性
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts.
32.4分
★☆☆☆☆
站内排序·非疗效
FRONTIER PAPERS
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts.
CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。